Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease Pharmaceutical Investing
Medtronic Executive Vice President and CFO to speak at Cowen healthcare conference Medical Device Investing
ALR Technologies Announces Successful Preliminary Results for the GluCurve Pet CGM Non-Inferiority Study Medical Device Investing
Bausch Health Announces Participation At The J.P. Morgan Global High Yield & Leveraged Finance Conference Pharmaceutical Investing
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration Medical Device Investing
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance Pharmaceutical Investing
Medtronic receives FDA approval for InterStim X system, the next generation of the most personalized sacral nerve stimulation therapy for bladder and bowel control Medical Device Investing
